| 股號 / 名稱 | 營收 | 稅後淨利 |
| ABT 美國雅培 | 424,484,714,944.29 | 30,010,446,303.6 |
| NVO 諾和諾德 | 391,313,578,874.41 | 104,643,776,207.76 |
| MDT 美敦力 | 318,241,211,019.48 | 48,277,674,488.4 |
| SYK 史賽克 | 214,933,511,624.37 | 41,623,184,221.08 |
| BSX Boston Scientific Corporation | 167,601,818,595.54 | 18,919,629,191.4 |
| PHG Koninklijke Philips N.V. | 162,504,479,050.77 | 14,386,864,429.72 |
| ZBH Zimmer Biomet Holdings, Inc. | 71,013,849,568.41 | 6,510,962,045.87 |
| RMD 瑞思邁 | 47,744,238,805.35 | 12,507,571,138.13 |
| NVST Envista Holdings Corporation | 23,828,946,766.07 | 1,751,696,702.72 |
| BIO Bio-Rad Laboratories, Inc. | 21,235,652,764.83 | 12,115,086,692.56 |
| QDEL QuidelOrtho Corp | 20,579,989,753.2 | -3,030,402,675.66 |
| BRBR BellRing Brands, Inc. | 18,606,476,708.23 | 1,115,605,721.29 |
| ICUI ICU Medical, Inc. | 17,995,927,226.21 | 524,334,689.0 |
| EYE National Vision Holdings, Inc. | 16,271,044,204.86 | 405,010,544.9 |
| PAHC Phibro Animal Health Corp | 12,941,907,108.28 | 708,181,292.66 |
| 2103 台橡 | 11,881,201,000 | 1,550,438,000 |
| HCM HUTCHMED (China) Ltd | 9,077,735,946.18 | 529,814,857.46 |
| TGTX TG Therapeutics, Inc. | 7,839,739,796.06 | 253,816,611.62 |
| WRBY Warby Parker Inc. | 7,682,380,673.27 | 151,487,513.73 |
| NEOG Neogen Corporation | 7,267,747,213.52 | -388,178,598.93 |
| ATRC AtriCure, Inc. | 5,010,570,210.89 | 292,112,550.71 |
| INMD InMode Ltd. | 3,118,117,990.99 | 556,628,538.83 |
| EOLS Evolus Inc | 2,742,824,311.95 | -262,656,645.26 |
| VMD Viemed Healthcare Inc | 2,547,528,070.62 | 94,598,145.96 |
| VALN Valneva SE | 2,454,003,992.01 | -2,358,402,159.73 |
| CERS Cerus Corp | 2,064,947,046.04 | -97,272,990.08 |
| MRVI Maravai Lifesciences Holdings, Inc. | 1,678,040,629.08 | -705,604,308.69 |
| INFU InfuSystem Holdings Inc | 1,204,756,318.84 | 105,395,382.62 |
| QTRX Quanterix Corporation | 1,073,395,376.16 | -1,596,229,542.85 |
| MGNX MacroGenics Inc | 1,070,981,492.43 | -2,271,725,545.08 |
| OMER Omeros Corporation | 930,617,415.86 | 216,499,274.04 |
| XGN Exagen Inc. | 650,476,423.63 | -104,253,680.85 |
| RMTI Rockwell Medical Inc | 579,984,494.87 | -38,230,698.99 |
| APYX Apyx Medical Inc | 452,896,778.78 | -100,208,794.61 |
| MYO Myomo Inc | 381,803,662.49 | -131,176,965.6 |
| 3285 微端 | 336,637,000 | 29,527,000 |
| CTSO Cytosorbents Corp | 314,228,944.83 | -144,082,762.31 |
| UTMD Utah Medical Products Inc | 278,216,409.26 | 87,617,455.19 |
| ICCC ImmuCell Corp | 234,411,269.88 | 59,846,701.54 |
| NEPH Nephros Inc | 196,274,842.84 | 39,046,200.25 |
| IMCC IM Cannabis Corp | 174,302,462.97 | -100,713,704.06 |
| UG United-Guardian Inc | 101,391,923.84 | 23,766,316.27 |
| SNES Senestech Inc | 25,117,438.75 | -59,759,932.2 |
| ORMP Oramed Pharmaceuticals Inc | 0.0 | 2,549,452,653.59 |
| CAPR Capricor Therapeutics, Inc. | 0.0 | -1,328,733,713.12 |
| VERU Veru Inc. | 0.0 | -227,960,328.72 |
| CLRB Cellectar Biosciences Inc | 0.0 | -226,078,151.82 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股營收排名、龍頭是誰？
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例